Investigation Overview
An investigation on behalf of investors of Global Blood Therapeutics, Inc. (NASDAQ: GBT) shares over potential securities laws violations by Global Blood Therapeutics and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Global Blo...
You must register (for free) or login to view the entire investigation.